Dynavax Technologies | Ativos

Assets Alterar Data
AbbVie USD 148.87B 12.65B 2024-03
Adma Biologics USD 350.88M 21.69M 2024-03
Amgen USD 92.98B 4.17B 2024-03
AstraZeneca USD 102.29B 1.17B 2024-03
Biogen USD 26.57B 277.2M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Dynavax Technologies USD 986.56M 10.53M 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
Glaxosmithkline GBP 58.51B 494M 2024-03
Merck USD 105.85B 878M 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
Novartis USD 94.33B 5.61B 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
Sarepta Therapeutics USD 3.22B 114.68M 2024-03
TG Therapeutics USD 373.32M 43.74M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



Dynavax Technologies Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.